Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22,921 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dosing Regimen Prediction and Confirmation With Rivaroxaban for Thromboprophylaxis in Children After the Fontan Procedure: Insights From the Phase III UNIVERSE Study.
Zhu P, Willmann S, Zhou W, Yang H, Michelson AD, McCrindle BW, Li JS, Harris KC, Pina LM, Weber T, Nessel K, Lesko LJ, Kubitza D, Zannikos P. Zhu P, et al. Among authors: zhou w. J Clin Pharmacol. 2022 Feb;62(2):220-231. doi: 10.1002/jcph.1966. Epub 2022 Jan 9. J Clin Pharmacol. 2022. PMID: 34524700 Free PMC article. Clinical Trial.
Model-informed bridging of rivaroxaban doses for thromboprophylaxis in pediatric patients aged 9 years and older with congenital heart disease.
Willmann S, Ince I, Ahsman M, Coboeken K, Zhang Y, Thelen K, Kubitza D, Zannikos P, Zhou W, Pina LM, Post T, Lippert J. Willmann S, et al. Among authors: zhou w. CPT Pharmacometrics Syst Pharmacol. 2022 Aug;11(8):1111-1121. doi: 10.1002/psp4.12830. Epub 2022 Jun 14. CPT Pharmacometrics Syst Pharmacol. 2022. PMID: 35665486 Free PMC article.
22,921 results
You have reached the last available page of results. Please see the User Guide for more information.